Utilization of FibroScan in Clinical Practice
- 1.9k Downloads
The evaluation of liver fibrosis is critical, particularly to rule out cirrhosis. Novel non-invasive tests such as transient ultrasound elastography are widely used to stage liver fibrosis as an alternative to liver biopsy, and this technology has recently been approved in the US. In this review, we discuss the performance characteristics of elastography for a variety of liver diseases and highlight practical appropriate suggestions for how to incorporate this technology into clinical practice.
KeywordsLiver fibrosis Cirrhosis Viral hepatitis Liver stiffness Ultrasound elastography
Compliance with Ethics Guidelines
Conflict of Interest
Nezam Afdhal has received research support from Merck, Glaxo Smith Kline, Vertex, Gilead, Abbott and BMS. Nezam Afdhal is a consultant/advisory board member for Merck, Gilead, Echosens, Glaxo Smith Kline, Vertex, Novartis, Boehringer Ingelheim, Ligand, Springbank, Medgenics and Kadmon. Afdhal has stock options in Springbank and Medgenics, and is Editor for the Journal of Viral Hepatitis. Alan Bonder has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 8.•Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2012;107:1862–71. The XL probe is an important tool for patients with obesity and high BMI for accurate LSM measurements.PubMedCrossRefGoogle Scholar
- 14.•Tapper EB, Cohen EB, Patel K, et al. Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2012;10:932–7. Elevated liver tests in patients with early stage fibrosis may cause an increase in LSM measurements and should be considered as a variable that can falsely raise liver stiffness.PubMedCentralPubMedCrossRefGoogle Scholar
- 15.••de Lédinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32:911–8. CAP with transient elastography is an accurate mode of measurement of liver steatosis and represents a novel additional benefit of the technology.PubMedCrossRefGoogle Scholar
- 16.European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;1:167–85.Google Scholar
- 34.••Klibansky DA, Mehta SH, Curry M, et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat. 2012;19:e184–93. Transient elastography is a good tool to stratify high-risk patients with chronic liver disease and can predict risk of liver decompensation.PubMedCrossRefGoogle Scholar
- 36.Singh S, Fujii LL, Murad MH, et al. Liver Stiffness Measurements are Associated with Risk of Decompensation, Liver Cancer, and Death in Patients with Chronic Liver Diseases: a Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2013;15:S1542–3565.Google Scholar